Alison Bauerlein
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Sight Sciences, Inc. (SGHT)
SEC 8-K
Current2025-11-05–present
-
Inogen Inc (INGN)
Proxy statement
Current -
Current
-
Current
-
Start not stated–2021-12-13
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Sight Sciences, Inc. (SGHT) | Chief Operating Officer | $474,900 | $1,626,754 |
| 2024 | Sight Sciences, Inc. (SGHT) | Chief Operating Officer | $450,000 | $2,238,543 |
| 2023 | Sight Sciences, Inc. (SGHT) | Chief Financial Officer | $306,185 | $1,848,183 |
| 2021 | Inogen Inc (INGN) | Former Executive Vice President, Finance and Chief Financial Officer | $368,412 | $1,920,973 |
| 2020 | Inogen Inc (INGN) | Former Executive Vice President, Finance and Chief Financial Officer | $369,823 | $1,173,453 |
| 2019 | Inogen Inc (INGN) | Former Executive Vice President, Finance and Chief Financial Officer | $365,458 | $1,170,980 |
| 2018 | Inogen Inc (INGN) | Executive Vice President, Finance and Chief Financial Officer | $355,212 | $1,242,433 |
| 2017 | Inogen Inc (INGN) | Executive Vice President, Finance and Chief Financial Officer | $336,251 | $1,157,235 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.